InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,619.94
(
-0.10%
)
US TECH 100
18,978.80
(
-0.48%
)
Dow Jones
41,269.22
(
0.05%
)
Brent Oil
77.53
(
-1.85%
)
Bitcoin
59,929.90
(
0.73%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Probart

Send PM Follow Ignore
Followers 37
Posts 4509
Boards Moderated 0
Alias Born 09/22/2009

Probart

Re: Investor100 post# 23066

Tuesday, 02/02/2010 7:08:26 PM

Tuesday, February 02, 2010 7:08:26 PM

Post# of 97239
The key is right here: “We were extremely pleased with our fourth quarter Cobroxin sales, especially given its initial limited retail availability,” explained Rik J Deitsch

All those sales were just internet and maybe some catalogue. With the 40,000 retail stores getting "into the cycle", Nyloxin, international markets, (maybe even military as there is a connection) etc, this current quarter we should see explosive sales.

BTW, if you have never heard CEO Rik Deitsch speak it is worth the time. Very smart man.

Cobroxin, tried and tested and living pain free for four months now.

Later.

insert-text-here

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up